ID   GLT12_HUMAN             Reviewed;         581 AA.
AC   Q8IXK2; Q5TCF7; Q8NG54; Q96CT9; Q9H771;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 3.
DT   03-AUG-2022, entry version 176.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 12;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 12;
DE            Short=GalNAc-T12;
DE            Short=pp-GaNTase 12;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 12;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12;
GN   Name=GALNT12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, TISSUE
RP   SPECIFICITY, AND VARIANT VAL-119.
RC   TISSUE=Lung;
RX   PubMed=12135769; DOI=10.1016/s0014-5793(02)03007-7;
RA   Guo J.-M., Zhang Y., Cheng L., Iwasaki H., Wang H., Kubota T.,
RA   Tachibana K., Narimatsu H.;
RT   "Molecular cloning and characterization of a novel member of the UDP-
RT   GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-
RT   T12(1).";
RL   FEBS Lett. 524:211-218(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Bennett E.P.;
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 144-581 (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   VARIANTS CRCS1 TRP-297; ASN-303; ASP-341; HIS-373; HIS-382; PHE-479 AND
RP   MET-491, CHARACTERIZATION OF VARIANTS CRCS1 TRP-297; ASN-303; ASP-341;
RP   HIS-373; HIS-382; PHE-479 AND MET-491, AND VARIANTS GLU-3; ARG-46; VAL-119;
RP   ASN-261; ARG-272 AND LYS-552.
RX   PubMed=19617566; DOI=10.1073/pnas.0901454106;
RA   Guda K., Moinova H., He J., Jamison O., Ravi L., Natale L., Lutterbaugh J.,
RA   Lawrence E., Lewis S., Willson J.K., Lowe J.B., Wiesner G.L.,
RA   Parmigiani G., Barnholtz-Sloan J., Dawson D.W., Velculescu V.E.,
RA   Kinzler K.W., Papadopoulos N., Vogelstein B., Willis J., Gerken T.A.,
RA   Markowitz S.D.;
RT   "Inactivating germ-line and somatic mutations in polypeptide N-
RT   acetylgalactosaminyltransferase 12 in human colon cancers.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12921-12925(2009).
RN   [7]
RP   VARIANTS CRCS1 ASN-303 AND CYS-396.
RX   PubMed=22461326; DOI=10.1002/humu.22088;
RA   Clarke E., Green R.C., Green J.S., Mahoney K., Parfrey P.S.,
RA   Younghusband H.B., Woods M.O.;
RT   "Inherited deleterious variants in GALNT12 are associated with CRC
RT   susceptibility.";
RL   Hum. Mutat. 33:1056-1058(2012).
RN   [8]
RP   INVOLVEMENT IN CRCS1.
RX   PubMed=24115450; DOI=10.1002/humu.22454;
RA   Segui N., Pineda M., Navarro M., Lazaro C., Brunet J., Infante M.,
RA   Duran M., Soto J.L., Blanco I., Capella G., Valle L.;
RT   "GALNT12 is not a major contributor of familial colorectal cancer type X.";
RL   Hum. Mutat. 35:50-52(2014).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide
CC       biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a
CC       serine or threonine residue on the protein receptor. Has activity
CC       toward non-glycosylated peptides such as Muc5AC, Muc1a and EA2, and no
CC       detectable activity with Muc2 and Muc7. Displays enzymatic activity
CC       toward the Gal-NAc-Muc5AC glycopeptide, but no detectable activity to
CC       mono-GalNAc-glycosylated Muc1a, Muc2, Muc7 and EA2. May play an
CC       important role in the initial step of mucin-type oligosaccharide
CC       biosynthesis in digestive organs.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O-
CC         [N-acetyl-alpha-D-galactosaminyl]-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:23956, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12788,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:53604,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:67138; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:12135769};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-
CC         O-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl-[protein] + H(+) +
CC         UDP; Xref=Rhea:RHEA:52424, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:67138, ChEBI:CHEBI:87075; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:12135769};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-
CC       pass type II membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IXK2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IXK2-2; Sequence=VSP_011217;
CC   -!- TISSUE SPECIFICITY: Widely expressed at different levels of expression.
CC       Highly expressed in digestive organs such as small intestine, stomach,
CC       pancreas and colon. Expressed at intermediate level in testis, thyroid
CC       gland and spleen. Weakly expressed in whole brain, cerebral cortex,
CC       cerebellum, fetal brain, bone marrow, thymus, leukocytes, heart,
CC       skeletal muscle, liver, lung, esophagus, kidney, adrenal gland, mammary
CC       gland, uterus, placenta, ovary and prostate.
CC       {ECO:0000269|PubMed:12135769}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif), which
CC       is probably involved in manganese coordination and substrate binding
CC       and the C-terminal domain (domain B, also called Gal/GalNAc-T motif),
CC       which is probably involved in catalytic reaction and UDP-Gal binding.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and contributes
CC       to the glycopeptide specificity. {ECO:0000250}.
CC   -!- DISEASE: Colorectal cancer 1 (CRCS1) [MIM:608812]: A complex disease
CC       characterized by malignant lesions arising from the inner wall of the
CC       large intestine (the colon) and the rectum. Genetic alterations are
CC       often associated with progression from premalignant lesion (adenoma) to
CC       invasive adenocarcinoma. Risk factors for cancer of the colon and
CC       rectum include colon polyps, long-standing ulcerative colitis, and
CC       genetic family history. {ECO:0000269|PubMed:19617566,
CC       ECO:0000269|PubMed:22461326, ECO:0000269|PubMed:24115450}. Note=Disease
CC       susceptibility is associated with variants affecting the gene
CC       represented in this entry. The role of GALNT12 in colon cancer
CC       susceptibility is however subject to discussion: studies on 103
CC       probants with colorectal cancer 1 (CRCS1) suggest that it does not act
CC       as a major contributor of CRCS1 (PubMed:24115450).
CC       {ECO:0000269|PubMed:24115450}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15027.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 12;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_495";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB078146; BAC07181.1; -; mRNA.
DR   EMBL; AJ132365; CAC80100.2; -; mRNA.
DR   EMBL; AL136084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013945; AAH13945.1; -; mRNA.
DR   EMBL; AK024865; BAB15027.1; ALT_INIT; mRNA.
DR   CCDS; CCDS6737.1; -. [Q8IXK2-1]
DR   RefSeq; NP_078918.3; NM_024642.4. [Q8IXK2-1]
DR   RefSeq; XP_006717350.1; XM_006717287.1.
DR   PDB; 6PXU; X-ray; 2.01 A; A/B=39-581.
DR   PDBsum; 6PXU; -.
DR   AlphaFoldDB; Q8IXK2; -.
DR   SMR; Q8IXK2; -.
DR   BioGRID; 122816; 118.
DR   IntAct; Q8IXK2; 33.
DR   MINT; Q8IXK2; -.
DR   STRING; 9606.ENSP00000364150; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   UniLectin; Q8IXK2; -.
DR   iPTMnet; Q8IXK2; -.
DR   PhosphoSitePlus; Q8IXK2; -.
DR   SwissPalm; Q8IXK2; -.
DR   BioMuta; GALNT12; -.
DR   DMDM; 84028209; -.
DR   EPD; Q8IXK2; -.
DR   jPOST; Q8IXK2; -.
DR   MassIVE; Q8IXK2; -.
DR   MaxQB; Q8IXK2; -.
DR   PaxDb; Q8IXK2; -.
DR   PeptideAtlas; Q8IXK2; -.
DR   PRIDE; Q8IXK2; -.
DR   ProteomicsDB; 71019; -. [Q8IXK2-1]
DR   ProteomicsDB; 71020; -. [Q8IXK2-2]
DR   Antibodypedia; 29005; 90 antibodies from 15 providers.
DR   DNASU; 79695; -.
DR   Ensembl; ENST00000375011.4; ENSP00000364150.3; ENSG00000119514.7. [Q8IXK2-1]
DR   GeneID; 79695; -.
DR   KEGG; hsa:79695; -.
DR   MANE-Select; ENST00000375011.4; ENSP00000364150.3; NM_024642.5; NP_078918.3.
DR   UCSC; uc004ayz.3; human. [Q8IXK2-1]
DR   CTD; 79695; -.
DR   DisGeNET; 79695; -.
DR   GeneCards; GALNT12; -.
DR   HGNC; HGNC:19877; GALNT12.
DR   HPA; ENSG00000119514; Tissue enhanced (epididymis, intestine, stomach).
DR   MalaCards; GALNT12; -.
DR   MIM; 608812; phenotype.
DR   MIM; 610290; gene.
DR   neXtProt; NX_Q8IXK2; -.
DR   OpenTargets; ENSG00000119514; -.
DR   PharmGKB; PA134929192; -.
DR   VEuPathDB; HostDB:ENSG00000119514; -.
DR   eggNOG; KOG3736; Eukaryota.
DR   GeneTree; ENSGT00940000157173; -.
DR   HOGENOM; CLU_013477_0_3_1; -.
DR   InParanoid; Q8IXK2; -.
DR   OMA; QFNWHAV; -.
DR   OrthoDB; 606683at2759; -.
DR   PhylomeDB; Q8IXK2; -.
DR   TreeFam; TF352660; -.
DR   BRENDA; 2.4.1.41; 2681.
DR   PathwayCommons; Q8IXK2; -.
DR   Reactome; R-HSA-5083636; Defective GALNT12 causes CRCS1.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   SignaLink; Q8IXK2; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 79695; 10 hits in 1077 CRISPR screens.
DR   ChiTaRS; GALNT12; human.
DR   GenomeRNAi; 79695; -.
DR   Pharos; Q8IXK2; Tbio.
DR   PRO; PR:Q8IXK2; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q8IXK2; protein.
DR   Bgee; ENSG00000119514; Expressed in palpebral conjunctiva and 151 other tissues.
DR   ExpressionAtlas; Q8IXK2; baseline and differential.
DR   Genevisible; Q8IXK2; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IBA:GO_Central.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IBA:GO_Central.
DR   CDD; cd02510; pp-GalNAc-T; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR045885; GalNAc-T.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disease variant; Disulfide bond;
KW   Glycosyltransferase; Golgi apparatus; Lectin; Manganese; Membrane;
KW   Metal-binding; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..581
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 12"
FT                   /id="PRO_0000059128"
FT   TOPO_DOM        1..19
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        20..37
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        38..581
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          445..577
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          43..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          135..244
FT                   /note="Catalytic subdomain A"
FT   REGION          304..366
FT                   /note="Catalytic subdomain B"
FT   COMPBIAS        51..67
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         176
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         205
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         228
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         230
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         335
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         363
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         371
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   DISULFID        125..358
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        349..422
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        458..479
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        506..521
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        547..566
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   VAR_SEQ         1..309
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011217"
FT   VARIANT         3
FT                   /note="G -> E (in dbSNP:rs1356894484)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064352"
FT   VARIANT         46
FT                   /note="G -> R (in dbSNP:rs10987768)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064353"
FT   VARIANT         119
FT                   /note="E -> V (in dbSNP:rs1137654)"
FT                   /evidence="ECO:0000269|PubMed:12135769,
FT                   ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064354"
FT   VARIANT         261
FT                   /note="D -> N (in dbSNP:rs41306504)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064355"
FT   VARIANT         272
FT                   /note="G -> R (in dbSNP:rs367645298)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064356"
FT   VARIANT         297
FT                   /note="R -> W (in CRCS1; germline mutation; partial loss of
FT                   activity; dbSNP:rs149726976)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064357"
FT   VARIANT         303
FT                   /note="D -> N (in CRCS1; germline mutation; reduction of
FT                   activity; dbSNP:rs145236923)"
FT                   /evidence="ECO:0000269|PubMed:19617566,
FT                   ECO:0000269|PubMed:22461326"
FT                   /id="VAR_064358"
FT   VARIANT         341
FT                   /note="E -> D (in CRCS1; somatic mutation; loss of
FT                   activity)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064359"
FT   VARIANT         373
FT                   /note="R -> H (in CRCS1; germline mutation; partial loss of
FT                   activity; dbSNP:rs920049418)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064360"
FT   VARIANT         382
FT                   /note="R -> H (in CRCS1; germline mutation; loss of
FT                   activity; dbSNP:rs868590153)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064361"
FT   VARIANT         396
FT                   /note="Y -> C (in CRCS1; dbSNP:rs1272530441)"
FT                   /evidence="ECO:0000269|PubMed:22461326"
FT                   /id="VAR_068509"
FT   VARIANT         479
FT                   /note="C -> F (in CRCS1; somatic mutation; loss of
FT                   activity)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064362"
FT   VARIANT         491
FT                   /note="T -> M (in CRCS1; germline mutation; loss of
FT                   activity; dbSNP:rs267606840)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064363"
FT   VARIANT         552
FT                   /note="R -> K (in dbSNP:rs1285871027)"
FT                   /evidence="ECO:0000269|PubMed:19617566"
FT                   /id="VAR_064364"
FT   STRAND          61..65
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   TURN            75..78
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           88..101
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           105..108
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           123..127
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   TURN            132..134
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          138..146
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           149..162
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           165..167
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          168..175
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           181..183
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           185..191
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           207..218
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          221..226
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          229..233
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           238..247
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          251..260
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   TURN            262..264
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          276..279
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          285..288
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           292..297
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          315..318
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           319..324
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          334..337
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           338..348
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          352..364
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           376..387
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           389..391
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           392..398
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           400..404
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           411..419
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           425..431
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          445..454
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          457..460
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          464..467
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          475..478
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           484..486
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          488..490
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          496..498
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          500..503
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          505..508
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          517..520
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           527..529
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          531..533
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          537..541
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   TURN            542..545
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          546..551
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   TURN            554..556
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          560..564
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   HELIX           570..572
FT                   /evidence="ECO:0007829|PDB:6PXU"
FT   STRAND          573..579
FT                   /evidence="ECO:0007829|PDB:6PXU"
SQ   SEQUENCE   581 AA;  66938 MW;  8C001D58E103A523 CRC64;
     MWGRTARRRC PRELRRGREA LLVLLALLAL AGLGSVLRAQ RGAGAGAAEP GPPRTPRPGR
     REPVMPRPPV PANALGARGE AVRLQLQGEE LRLQEESVRL HQINIYLSDR ISLHRRLPER
     WNPLCKEKKY DYDNLPRTSV IIAFYNEAWS TLLRTVYSVL ETSPDILLEE VILVDDYSDR
     EHLKERLANE LSGLPKVRLI RANKREGLVR ARLLGASAAR GDVLTFLDCH CECHEGWLEP
     LLQRIHEEES AVVCPVIDVI DWNTFEYLGN SGEPQIGGFD WRLVFTWHTV PERERIRMQS
     PVDVIRSPTM AGGLFAVSKK YFEYLGSYDT GMEVWGGENL EFSFRIWQCG GVLETHPCSH
     VGHVFPKQAP YSRNKALANS VRAAEVWMDE FKELYYHRNP RARLEPFGDV TERKQLRDKL
     QCKDFKWFLE TVYPELHVPE DRPGFFGMLQ NKGLTDYCFD YNPPDENQIV GHQVILYLCH
     GMGQNQFFEY TSQKEIRYNT HQPEGCIAVE AGMDTLIMHL CEETAPENQK FILQEDGSLF
     HEQSKKCVQA ARKESSDSFV PLLRDCTNSD HQKWFFKERM L
//
